Articles

Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;Cote d’Azur University, INSERM U1065, Centre Méditerranéen de Medecine Moléculaire, Nice, France;Groupe Français des Myélodysplasies, Paris, France
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Hematology Unit, AOU Careggi, Firenze, Italy
Groupe Français des Myélodysplasies, Paris, France;Senior Hematology Unit, Saint Louis Hospital, Paris, France
H. Lee Moffitt Cancer Center and Research Institute and the Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, USA
Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA
Cote d’Azur University, INSERM U1065, Centre Méditerranéen de Medecine Moléculaire, Nice, France
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Groupe Français des Myélodysplasies, Paris, France;Senior Hematology Unit, Saint Louis Hospital, Paris, France
Hematology Unit, AOU Careggi, Firenze, Italy
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Vol. 102 No. 12 (2017): December, 2017 https://doi.org/10.3324/haematol.2016.158857